These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38669827)

  • 21. Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B.
    You J; Sriplung H; Geater A; Chongsuvivatwong V; Zhuang L; Chen HY; Yu L; Tang BZ; Huang JH
    World J Gastroenterol; 2008 Feb; 14(7):1112-9. PubMed ID: 18286696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating PD-1
    Zhang L; Li H; Ren H; Hu P
    Mol Immunol; 2018 Nov; 103():270-278. PubMed ID: 30340072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
    Zhou Y; Zhang H; Li Y
    Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
    Li C; Ji H; Cai Y; Ayana DA; Lv P; Liu M; Jiang Y
    J Interferon Cytokine Res; 2013 Oct; 33(10):612-8. PubMed ID: 23697556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients.
    Gu Y; Lian Y; Gu L; Chen L; Li X; Zhou L; Huang Y; Wang J; Huang Y
    BMC Infect Dis; 2019 Mar; 19(1):216. PubMed ID: 30832595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity.
    Narmada BC; Khakpoor A; Shirgaonkar N; Narayanan S; Aw PPK; Singh M; Ong KH; Owino CO; Ng JWT; Yew HC; Binte Mohamed Nasir NS; Au VB; Sng R; Kaliaperumal N; Khine HHTW; di Tocco FC; Masayuki O; Naikar S; Ng HX; Chia SL; Seah CXY; Alnawaz MH; Wai CLY; Tay AYL; Mangat KS; Chew V; Yu W; Connolly JE; Periyasamy G; Plissonnier ML; Levrero M; Lim SG; DasGupta R
    J Hepatol; 2024 Jul; 81(1):42-61. PubMed ID: 38423478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
    Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
    Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of hepatitis B virus intrahepatic covalently closed circular DNA and serum viral markers in treatment-naive patients with acute and chronic HBV infection.
    Li W; Zhao J; Zou Z; Liu Y; Li B; Sun Y; Li X; Liu S; Cai S; Yao W; Xin S; Lu F; Xu D
    PLoS One; 2014; 9(2):e89046. PubMed ID: 24551214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.
    Le Bert N; Gill US; Hong M; Kunasegaran K; Tan DZM; Ahmad R; Cheng Y; Dutertre CA; Heinecke A; Rivino L; Tan A; Hansi NK; Zhang M; Xi S; Chong Y; Pflanz S; Newell EW; Kennedy PTF; Bertoletti A
    Gastroenterology; 2020 Aug; 159(2):652-664. PubMed ID: 32302614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate.
    TrehanPati N; Kotillil S; Hissar SS; Shrivastava S; Khanam A; Sukriti S; Mishra SK; Sarin SK
    J Clin Immunol; 2011 Jun; 31(3):509-20. PubMed ID: 21305387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
    Werner JM; Abdalla A; Gara N; Ghany MG; Rehermann B
    Gastroenterology; 2013 Nov; 145(5):1026-34. PubMed ID: 23916846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Programmed death 1 expressing CD8
    Khanam A; Tang LSY; Kottilil S
    Hepatology; 2022 Mar; 75(3):690-708. PubMed ID: 34689344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection.
    Gu S; Fu X; Ye G; Chen C; Li X; Zhong S; Tang L; Chen H; Jiang D; Hou J; Li Y
    Front Immunol; 2021; 12():649197. PubMed ID: 34234772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrepant Clinical Significance of CD28
    Shen XH; Xu P; Yu X; Song HF; Chen H; Zhang XG; Wu MY; Wang XF
    Viral Immunol; 2018 Oct; 31(8):548-558. PubMed ID: 30117787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.
    Lai Q; Ma S; Ge J; Huang Z; Huang X; Jiang X; Li Y; Zhang M; Zhang X; Sun J; Abbott WG; Hou J
    PLoS One; 2014; 9(2):e88475. PubMed ID: 24551107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients.
    Farnik H; Bojunga J; Berger A; Allwinn R; Waidmann O; Kronenberger B; Keppler OT; Zeuzem S; Sarrazin C; Lange CM
    Hepatology; 2013 Oct; 58(4):1270-6. PubMed ID: 23703797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus DNA is more powerful than HBeAg in predicting peripheral T-lymphocyte subpopulations in chronic HBV-infected individuals with normal liver function tests.
    You J; Sriplung H; Geater A; Chongsuvivatwong V; Zhuang L; Chen HY; Huang JH; Tang BZ
    World J Gastroenterol; 2008 Jun; 14(23):3710-8. PubMed ID: 18595137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.